CONCLUSIONS
We conclude, from our results, that the use of BIMA in coronary revascularization offers a long-term survival benefit compared to SIMA, and that the use of BIMA does not increase the rate of postoperative complications, including deep sternal wound infection.
Excellent outcome can be achieved with OPCAB BIMA in real world practice with adequate patient selection.